Therapeutic Advances: New Hope for Patients With ALS
by Instructor: Francesca Monachino, OTR/L
Credentialed for: Nursing CEU Courses | Nursing CE | ContinuingEducation.com

$20.00

i 1.00 CEH

Course Overview

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease involving the upper and lower motor neurons that control voluntary movement. When neurons can no longer transmit impulses to the muscles, the muscles begin to atrophy, and weakness increases over time. The diagnosis of ALS is established by the finding of selective populations of motor neurons, including the descending supraspinal motor pathways and their neurons of origin, and of the brainstem and spinal motor neurons. According to The ALS Association, based on population studies, there are about 5,600 new cases of ALS diagnosed each year. ALS is 20% more common in men than in women; however, as each group ages, the incidence equalizes. ALS incidence rates are increasing more rapidly than can be accounted for from an aging population. Researchers are showing renewed interest in environmental factors.

About the Course Author

Francesca Monachino, OTR/L, is an occupational therapist at Duke Health who provides services at the Duke ALS Clinic. Francesca Monachino, OTR/L has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Get started now and your first course is free!
CE-PRO Membership
Become a member today and enjoy instant savings on all courses
$19.95 / year

CE-PRO is a membership program that gives you 50% OFF everything you buy and much more.

CE-PRO Membership Benefits

50% Discount on All Course Purchases

Free CE Alerts

Detailed Transcripts

License Tracking/Reminders

Accreditation Information

Certificates provided by accrediting body (5 Match)

  • American Occupational Therapy Association

    1.00HOURS

    Relias Learning is an approved provider of continuing education courses by the American Occupational Therapy Association. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. Category 1 & 2. This activity is approved for 1.0 contact hours.
  • Florida Board of Occupational Therapy

    1.00HOURS

    This course has been approved by the Florida Board of Occupational Therapy for 1.0 contact hours, approval number 20-717852.
  • New Jersey State Board of Physical Therapy

    1.00HOURS

    This course was approved by the New Jersey Board of Physical Therapy Examiners. Approval #: 1910-184. This activity is approved for 1.0 contact hours.
  • Alabama State Board of Occupational Therapy

    1.00HOURS

    This course has been approved by the Alabama State Board of Occupational Therapy for 1.0 contact hours, approval number 20-717852.
  • Accreditation Council for Continuing Medical Education

    1.00HOURS

    Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Relias LLC designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Course Details

  • Course Code:

    REL-ACU-0-OT189
  • Hours:

    1.00
  • Type:

    Online Course
  • Release Date:

    2019-05-01
  • Expiration Date:

    2022-02-14
  • Learning Objectives:

    Cite three nervous system functions that remain unaffected in ALS; List four important functions of the healthcare professional in the care of patients with ALS; List four symptoms and signs of ALS
  • Outline:

     

    Section 1: Introduction

    Section 2: The Facts about ALS

    Section 3: Fast Facts

    Section 4: Testing Used in ALS

    Section 5: Deciphering the Clues

    Section 6: Slowing the Progression

    - Fast Facts About Riluzole

    Section 7: Special Education Needs of ALS Patients Who Take Riluzole

    Section 8: Scope of Symptoms

    - Treatment for Common ALS Symptoms

    Section 9: More Than Just Drugs

    Section 10: Investigations of Potential Treatments

    - IGF-1

    - COX2 inhibitor celecoxib (Celebrex)

    - Minocycline (Minocin)

    - Co-enzyme Q10 (CoQ10)

    - Creatine

    - Glatiramer acetate (Copaxone)

    - Stem cell research

    - Gene therapy

    - Ceftroaxone

    - Dexpramipexole

    Section 11: Long-Term Healthcare Needs of Patients with ALS: Focus on the psychosocial

    - Stressors Experienced by Patients with Terminal Illness

    Section 12: The Multidisciplinary Team's Role in ALS

    - Healthcare Professionals' Role in the Care of Patients with ALS

  • Target Audience:

    The target audience for this course is: intermediate level Occupational Therapists; intermediate level Speech and Language Pathologists; Physical Therapists; Physicians; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.
News & Information
blog
New CMS Rule Gives Dietitians Order-Writing Privileges

Starting July 11, 2014, Registered Dietitian Nutritionists will be able to order diets in hospitals under Centers for Medicare and Medicaid Services (CMS) regulation …

Read More
blog
Leader in Online Education for Healthcare Professionals

ContinuingEducation.com is the leader in online education for healthcare professionals. We are the first choice for hundreds of healthcare organizations and hundreds of thousands of individuals …

Read More
blog
A Complete Guide to CE for Dietitians and Nutritionists

As a Registered Dietitian (RD), or soon to be, you play a vital role in the healthcare community by providing expert advice on proper food and nutrition, counseling clients …

Read More